Medistim ASA (OSL:MEDI) EPS (Diluted) : kr5.60 (TTM As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA EPS (Diluted)?

Medistim ASA's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was kr1.33. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr5.60.

Medistim ASA's EPS (Basic) for the three months ended in Mar. 2024 was kr1.33. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was kr5.60.

Medistim ASA's EPS without NRI for the three months ended in Mar. 2024 was kr1.33. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was kr5.60.

During the past 12 months, Medistim ASA's average EPS without NRIGrowth Rate was -11.70% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 14.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 15.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Medistim ASA's highest 3-Year average EPS without NRI Growth Rate was 47.60% per year. The lowest was -12.30% per year. And the median was 13.50% per year.

Medistim ASA EPS (Diluted) Historical Data

The historical data trend for Medistim ASA's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA EPS (Diluted) Chart

Medistim ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Diluted)

Get a 7-Day Free Trial

3.86

3.80

4.98

6.24

5.67

Medistim ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Diluted)	Get a 7-Day Free Trial															1.40	1.80	1.43	1.04	1.33

Competitive Comparison of Medistim ASA's EPS (Diluted)

For the Medical Devices subindustry, Medistim ASA's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medistim ASA's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's PE Ratio distribution charts can be found below:

* The bar in red indicates where Medistim ASA's PE Ratio falls into.

Medistim ASA EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Medistim ASA's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(103.823	-	0)	/	18.296
	=	5.67

Medistim ASA's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(24.38	-	0)	/	18.314
	=	1.33

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr5.60

Medistim ASA (OSL:MEDI) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Medistim ASA EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Medistim ASA's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Medistim ASA (OSL:MEDI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSL:MEDI) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

MEDIO:Sweden MD1:Germany

Address

Okernveien 94, Oslo, NOR, 0579

Website

https://www.medistim.com

Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing and sales of medical equipment through its own business or through participation in other companies, as well related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, Asia and the Rest of the World. The firm's activity is split into three strategic operating units, Lease of equipment; Lease of equipment and Distribution and sales of third-party products.